These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5165301)

  • 1. Fibrinolytic activity in venous blood of patients with muscular dystrophy.
    Menon IS; Gardner-Medwin D; Weightman D; Dewar HA
    Neurology; 1971 Oct; 21(10):1019-22. PubMed ID: 5165301
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of fibrinolysis in muscular dystrophy.
    Berman PH; Nigro MA; Harris MB; Oski FA
    Arch Neurol; 1973 Jul; 29(1):65-6. PubMed ID: 4711808
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood clotting and fibrinolytic studies in patients with muscular dystrophy.
    Bond TP; Guest MM
    Tex Rep Biol Med; 1964 Dec; 22():Suppl 1:886-9. PubMed ID: 5830976
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of determination of various leukocyte enzymes in progressive muscular dystrophy].
    Dembek I; Lukasiuk M
    Neurol Neurochir Pol; 1981; 15(3):291-6. PubMed ID: 6458775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscular dystrophy: clinical, electrical, histological and biochemical study.
    Desai AD; Braganca BM; Divekar AY; Bubelis I; Deshpande DH; Rebello MD
    Neurol India; 1966; 14(4):167-73. PubMed ID: 5977713
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of fibrinolytic activity to venous occlusion.
    Shaper AG; Marsh NA; Patel I; Kater F
    Br Med J; 1975 Sep; 3(5983):571-3. PubMed ID: 1174826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocytes in human muscular dystrophy.
    Miale TD; Frias JL; Lawson DL
    Science; 1975 Feb; 187(4175):453-4. PubMed ID: 1111115
    [No Abstract]   [Full Text] [Related]  

  • 9. [Muscular dystrophy and its problems].
    Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
    Nihon Rinsho; 1968 Sep; 26(9):2184-98. PubMed ID: 5752294
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypoxanthine-guanine phosphoribosyltransferase activity of blood and muscle in Duchenne dystrophy.
    Neerunjun JS; Allsop J; Dubowitz V
    Muscle Nerve; 1979; 2(1):19-23. PubMed ID: 545141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperresponsivness of patients with clinical and premyopathic myotonic dystrophy to human growth hormone.
    Heymsfield SB; Bethel RA; Rudman D
    J Clin Endocrinol Metab; 1977 Jul; 45(1):147-58. PubMed ID: 874060
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscle adenylic acid deaminase activity. Selective decrease in early-onset Duchenne muscular dystrophy.
    Kar NC; Pearson CM
    Neurology; 1973 May; 23(5):478-82. PubMed ID: 4735464
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study of carrier detection of Duchenne type progressive muscular dystrophy by serum myoglobin measurement (author's transl)].
    Konagaya M; Takayanagi T; Konagaya Y; Sobue I
    Rinsho Shinkeigaku; 1982 Jan; 22(1):30-5. PubMed ID: 7094482
    [No Abstract]   [Full Text] [Related]  

  • 14. Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Seventeen cases in eight families including an autopsied case.
    Miyoshi K; Kawai H; Iwasa M; Kusaka K; Nishino H
    Brain; 1986 Feb; 109 ( Pt 1)():31-54. PubMed ID: 3942856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum creatine kinase activity in patients with Duchenne-type dystrophy and in their mothers following physical effort].
    Hetnarska L
    Neurol Neurochir Pol; 1971; 5(5):653-7. PubMed ID: 5161075
    [No Abstract]   [Full Text] [Related]  

  • 16. Deformed erythrocytes in muscular dystrophies.
    Grassi E; Lucci B; Marchini C; Ottonello S; Parma M; Reggiani R; Rossi GL; Tagliavini J
    Neurology; 1978 Aug; 28(8):842-4. PubMed ID: 567302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological variations of erythrocytes in Duchenne muscular dystrophy and in carrier state.
    Capriotti M; Dellantonio R; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G; Leporoni B
    Boll Soc Ital Biol Sper; 1980 Jul; 56(14):1459-64. PubMed ID: 7448043
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study of sialic acid of erythrocyte membranes in Duchenne muscular dystrophy].
    Shen DG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Dec; 21(6):349-51, 385. PubMed ID: 3248452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genetics and clinical types of progressive muscular dystrophy; creatine kinase and myoglobin as biochemical indices of the disease].
    Miyoshi K; Kawai H; Sasaki H; Iwaasa M; Yagita M; Ise H; Kondo A; Hiasa M
    Nihon Rinsho; 1977 Nov; 35(11):3891-6. PubMed ID: 599669
    [No Abstract]   [Full Text] [Related]  

  • 20. [A family of scapula-back type of x-linked recessive muscular dystrophy].
    Ji XW
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):136-8, 190. PubMed ID: 2591265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.